You have accessRestricted Access
A Tailored Therapy for the Metabolic SyndromeThe Dual Peroxisome Proliferator-Activated Receptor-α/γ Agonist LY465608 Ameliorates Insulin Resistance and Diabetic Hyperglycemia While Improving Cardiovascular Risk Factors in Preclinical Models
Garret J. Etgen, Brian A. Oldham, William T. Johnson, Carol L. Broderick, Chahrzad R. Montrose, Joseph T. Brozinick, Elizabeth A. Misener, James S. Bean, William R. Bensch, Dawn A. Brooks, Anthony J. Shuker, Christopher J. Rito, James R. McCarthy, Robert J. Ardecky, John S. Tyhonas, Sharon L. Dana, James M. Bilakovics, James R. Paterniti, Kathleen M. Ogilvie, Sha Liu and Raymond F. Kauffman